Regulator cautions Kenyans against Diclofenac
The Pharmacy and Poisons Board has flagged the use of ‘Non-Steroidal Anti-Inflammatory Drugs’ (NSAIDs), specifically Diclofenac for pain management. In a statement on Friday, May 20, 2022, the Board said that NSAIDs as a class, if used at high dosage and for long periods, are associated with an increased risk of blood clots in the […]